מדיטבין 200 מ"ג

Country: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

GEMCITABINE AS HYDROCHLORIDE 200 MG/VIAL

থেকে পাওয়া:

MEDISON PHARMA LTD

এটিসি কোড:

L01BC05

ফার্মাসিউটিকাল ফর্ম:

POWDER FOR SOLUTION FOR INFUSION

প্রশাসন রুট:

I.V

Manufactured by:

INTAS PHARMACEUTICALS LTD, INDIA

Therapeutic group:

GEMCITABINE

থেরাপিউটিক ইঙ্গিত:

Palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-FU refractory pancreatic cancer. Gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. Breast cancer: Gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherapy should have included an anthracycline unless clinically contraindicated. Ovarian cancer: Gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

অনুমোদন তারিখ:

2012-11-01